Revance Therapeutics Equity 2024

Revance Therapeutics Aktienanalyse

What does Revance Therapeutics do?

Revance Therapeutics Inc is a US-based biopharmaceutical company that specializes in the development and marketing of novel treatments in dermatology, neurology, and aesthetic medicine. The company was founded in 2002 and is headquartered in Newark, California. Translated: Revance Therapeutics Inc is a US-based biopharmaceutical company that specializes in the development and marketing of novel treatments in dermatology, neurology, and aesthetic medicine. The company was founded in 2002 and is headquartered in Newark, California. Revance Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Revance Therapeutics's Equity

Revance Therapeutics's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Revance Therapeutics's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Revance Therapeutics's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Revance Therapeutics's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Revance Therapeutics’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Revance Therapeutics stock

What is the equity of Revance Therapeutics this year?

Revance Therapeutics has equity of -151.6 M USD this year.

What was the equity of Revance Therapeutics compared to the previous year?

The equity of Revance Therapeutics has increased/decreased by -1,303.21% decreased compared to the previous year.

What impact does a high equity have on investors of Revance Therapeutics?

A high equity is advantageous for investors of Revance Therapeutics as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Revance Therapeutics?

A low equity can be a risk for investors of Revance Therapeutics, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Revance Therapeutics affect the company?

An increase in equity of Revance Therapeutics can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Revance Therapeutics affect the company?

A reduction in equity of Revance Therapeutics can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Revance Therapeutics?

Some factors that can affect the equity of Revance Therapeutics include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Revance Therapeutics so important for investors?

The equity of Revance Therapeutics is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Revance Therapeutics take to change the equity?

To change equity, Revance Therapeutics can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Revance Therapeutics pay?

Over the past 12 months, Revance Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Revance Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Revance Therapeutics?

The current dividend yield of Revance Therapeutics is .

When does Revance Therapeutics pay dividends?

Revance Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Revance Therapeutics?

Revance Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Revance Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Revance Therapeutics located?

Revance Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Revance Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Revance Therapeutics from 10/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/6/2024.

When did Revance Therapeutics pay the last dividend?

The last dividend was paid out on 10/6/2024.

What was the dividend of Revance Therapeutics in the year 2023?

In the year 2023, Revance Therapeutics distributed 0 USD as dividends.

In which currency does Revance Therapeutics pay out the dividend?

The dividends of Revance Therapeutics are distributed in USD.